Hypertension Clinical Trial
Official title:
Can Obstructive Sleep Apnea Impair Cardiorespiratory Responses to Aerobic Exercise in Hypertensive Elderly?
Elderly have a high prevalence to systemic arterial hypertension (SAH) and obstructive sleep apnea (OSA). Both comorbidities are closely associated and inflict injury cardiorespiratory capacity. To assess cardiorespiratory responses to the cardiopulmonary exercise test (CPET) among hypertensive elderly with OSA. We enrolled 25 elderly hypertensive in two different groups: without OSA (No-OSA: Apnea/Hypopnea Index (AHI) < 5 events/h; n = 15) and with OSA (OSA: AHI ≥ 15 events/h; n = 13). All subjects underwent a CPET and polysomnographic assessments. After normality and homogeneity evaluations, independent t test and pearson's correlation were performed. The significance level was p ≤ 0.05.
The sample was randomly recruited from the Lauro Wanderley University Hospital and older
people living together centers located in João Pessoa/PB (Brazil). All subjects were
submitted to anthropometric assessments (body mass index, neck circumference, hip
circumference and waist circumference), polysomnography, echocardiography, cardiopulmonary
exercise test (CPET). Moreover, they were submitted to a sleep quality questionnaire
(Pittsburgh Sleep Quality Index).
Cardiopulmonary Exercise Test Protocol All subjects performed an incremental cardiopulmonary
exercise test (CPET) of maximum exercise tolerance. All procedures were performed in
agreement with the guidelines of the American Thoracic Society/American College of Chest
Physicians for cycle ergometer tests. The CPET was performed on an Inbrasport CG-04 cycle
ergometer (Inbrasport, Porto Alegre, Rio Grande do Sul, Brazil) with electromagnetic braking.
Subjects performed a 5-min warm-up with no resistance (0 W), then the activity rate was
increased using a ramp protocol (5-10 W.min-1) until maximum exercise tolerance. Verbal
encouragements were given during the CPET to ensure maximal effort.
Pulmonary gas exchange variables (VO2, VCO2, minute ventilation [VE], oxygen pulse (O2Pu),
respiratory quotient (R), ventilatory efficiency index (VE/VCO2slope), cardiovascular
function index (ΔHR/ΔVO2), deviation from oxygen consumption efficiency (OUES), metabolic
efficiency index (VO2/ΔWR), blood pressure (BP), heart rate (HR) recovery at first (HRR1) and
second (HRR2) minutes were measured breath-by-breath with an on-line gas expiration analysis
system (VO2000, MedGraphics, St. Paul, Minnesota, USA). Peak values were established by the
highest values achieved during effort.
Polysomnography Assessment All hypertensive subjects were submitted to a polysomnography exam
to diagnose OSA. OSA diagnosis was confirmed by the apnea/hypopnea index (AHI) and classified
as follows: AHI < 5 events/h, absence of OSA; 5 ≤ AHI ≤ 15 events/h, low OSA; 15 ≤ AHI ≤ 30
events/h, moderate OSA; AHI > 30 events/h, severe OSA.
The assessment was carried out during an entire night of sleep in the participant's residence
without the use of sedatives. The variables were monitored by an Embletta portable
respiratory monitor (Embla, Embletta® Gold, EUA), previously validated and in agreement with
manufacturer's instructions. The Embletta monitor is capable to continuously monitor pulse
oximetry, to detect respiratory efforts, to measure the airflow, and to record snoring
episodes. Additionally, HR was continually measured by the analysis of pulse waves by
oximetry. Finally, brain and muscle activities were monitored by electrodes, and oxygen
desaturation (O2D) was defined as the amount of reduction in O2S at 4%/h.
Echocardiography All subjects performed the two-dimensional color Doppler echocardiogram
(iE33® - Philips Electronics, Netherlands) before the CPET. Final systolic and diastolic
diameters of the left ventricle and the diastolic thickness of the posterior wall of the left
ventricle were measured from the short-axis view, and ejection fraction was obtained from
these measures. This exam was conducted by an experienced cardiologist, who was blinded to
group allocation.
Sleep Quality The subjective sleep quality was assessed by the Pittsburgh Sleep Quality
Index, which consists of 19 questions grouped into 7 different components (subjective sleep
quality, sleep latency, sleep duration, sleep efficiency, sleep disorders, use of
medications, and diurnal dysfunction). The classifications depended upon the scores reached
in each question (from 0 to 3); ranging from 0 - 4: good subjective sleep quality; 5 - 10:
bad subjective sleep quality; and 11 or higher: indicates the presence of at least one sleep
disorder.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |